Gold nanoparticles enhance cisplatin delivery and potentiate chemotherapy by decompressing colorectal cancer vessels
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tumor vessels were persistently compressed by solid stress from tumor interstitial matrix, resulting in limited vessel perfusion and oxygen concentrations. Collagen within matrix participated in transmitting the solid stress to tumor vessels and limiting drug delivery. PURPOSE: The objective of this study was to identify whether gold nanoparticles (AuNPs) were able to decompress colorectal cancer vessels and enhance vessel perfusion as well as drug delivery in colorectal cancer. METHODS: Colorectal cancer xenograft mice were treated with AuNPs or normal saline for 14 days. The cancer stromal collagen I level, cancer vessel perfusion, hypoxia of tumor were tested by histological examination. We also test the solid stress in the two groups. Furtherly, the effect and the drug delivery of combined using AuNPs and cisplatin were tested. The effect and the underlying mechanism of AuNPs on SW620 cells were tested by CCK8, flow cytometry, Western-blot and atomic force microscope. RESULTS: AuNPs were able to decrease the density of colorectal cancer associated fibroblasts (CAFs), to reduce the production of tumor stromal collagen I, and to diminish the expression of profibrotic signals, including CTGF, TGF-β1 as well as VEGF in vivo and vitro via Akt signaling pathway. Consequently, AuNPs could alleviate solid stress in tumors, subsequently leading to enhanced vessel perfusion. Therefore, cisplatin as well as oxygen delivery to tumors were improved by AuNPs, which reduced hypoxia while sensitizing therapy of cisplatin in colorectal cancer model. CONCLUSION: AuNPs were effective agents in enhancing cisplatin delivery and potentiating inhibiting tumor growth by decompressing colorectal cancer vessels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, gold nanoparticles have been used to effectively deliver various anti-CRC therapies to tumor cells, including chemotherapy drugs and anti-EGFR inhibitors, resulting in enhanced anticancer drug efficacy [110,111,112].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [111]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · cited 1×
“CAFs are typically iden-tified by α -SMA, a myocyte marker 23,24 and other agents, such as fibroblast-specific protein (FSP-1).”
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
The extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201102147 · Cited by 3,024 · cited 1×
“31,32 In consideration of the collagen density in breast cancers and fibrosis in hepatic cancer as independent risk factors, dense ECM and fibrosis are likely to be involved in tumor initiation.”
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Mammographic Density and the Risk and Detection of Breast Cancer
Boyd, N. F., Guo, H., Martin, L. J., Sun, L., Stone, J., Fishell, E., Jong, R. A., Hislop, G., Chiarelli, A., Minkin, S., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062790 · Cited by 2,478
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
Nasir, O. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331
Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., & Sahai, E. (2007) · Nature Cell Biology · doi:10.1038/ncb1658 · Cited by 1,589 · cited 1×
“38,39 In spite of the impediment in larger drug distribution by steric interplays with collagen, the delivery of smaller chemotherapy agents is not directly blocked, 40 which, however, is indirectly hindered by vessel compression.”
Aligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma
Conklin, M. W., Eickhoff, J. C., Riching, K. M., Pehlke, C. A., Eliceiri, K. W., Provenzano, P. P., Friedl, A., & Keely, P. J. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.076 · Cited by 1,285
Cited by
Biomedical applications of metallic nanoparticles in cancer: Current status and future perspectives
Khursheed, R., Dua, K., Vishwas, S., Gulati, M., Jha, N. K., Aldhafeeri, G. M., Alanazi, F. G., Goh, B. H., Gupta, G., Paudel, K. R., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112951 · Cited by 286
Fibroblasts in the Tumor Microenvironment
Truffi, M., Sorrentino, L., & Corsi, F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-37184-5_2 · Cited by 154
Engineered nanoparticles for imaging and drug delivery in colorectal cancer
Pavitra, E., Dariya, B., Srivani, G., Kang, S.-M., Alam, A., Sudhir, P.-R., Kamal, M. A., Raju, G. S. R., Han, Y.-K., Lakkakula, B. V. K. S., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.017 · Cited by 102
Gold nanoparticles: synthesis, physiochemical properties and therapeutic applications in cancer
Liu, X., Wang, J., Ashby, C. R., Zeng, L., Fan, Y., & Chen, Z. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.01.030 · Cited by 144
Nanotechnology in Colorectal Cancer for Precision Diagnosis and Therapy
Brar, B., Ranjan, K., Palria, A., Kumar, R., Ghosh, M., Sihag, S., & Minakshi, P. (2021) · Frontiers in Nanotechnology · doi:10.3389/fnano.2021.699266 · Cited by 115
Advances in Gold Nanoparticle-Based Combined Cancer Therapy
Bromma, K., & Chithrani, D. B. (2020) · Nanomaterials · doi:10.3390/nano10091671 · Cited by 102
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
Nanotheranostics Targeting the Tumor Microenvironment
Roma‐Rodrigues, C., Pombo, I., Raposo, L. R., Pedrosa, P., Fernandes, A. R., & Baptista, P. V. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00197 · Cited by 84
Nanotechnology for colorectal cancer detection and treatment
Gogoi, P., Kaur, G., & Singh, N. K. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i46.6497 · Cited by 82
Kovács, D., Igaz, N., Marton, A., Rónavári, A., Bélteky, P., Bodai, L., Spengler, G., Tiszlavicz, L., Rázga, Z., Hegyi, P. J., et al. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-0576-x · Cited by 80
Nano-targeting vascular remodeling in cancer: Recent developments and future directions
Giordo, R., Wehbe, Z., Paliogiannis, P., Eid, A. H., Mangoni, A. A., & Pintus, G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.001 · Cited by 73
Gold nanomaterials for oral cancer diagnosis and therapy: Advances, challenges, and prospects
Zhang, Q., Hou, D., Wen, X., Xin, M., Li, Z., Wu, L., & Pathak, J. L. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100333 · Cited by 67
Recent progress on nanomedicine-induced ferroptosis for cancer therapy
Zafar, H., Raza, F., Ma, S., Wei, Y., Zhang, J., & Shen, Q. (2021) · Biomaterials Science · doi:10.1039/d1bm00721a · Cited by 63
Nanoparticles: Attractive tools to treat colorectal cancer
Younis, N. K., Roumieh, R., Bassil, E. P., Ghoubaira, J. A., Kobeissy, F. H., & Eid, A. H. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.08.006 · Cited by 63
Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances
Kasi, P. B., Mallela, V. R., Ambrożkiewicz, F., Trailin, A. V., Liška, V., & Hemminki, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097922 · Cited by 57
El Hallal, R., Lyu, N., & Wang, Y. (2021) · Molecules · doi:10.3390/molecules26030567 · Cited by 51
Jiang, H., Ge, H., Shi, Y., Yuan, F., & Yue, H. (2023) · Medical Oncology · doi:10.1007/s12032-023-01953-7 · Cited by 48
Orally Administrable Therapeutic Nanoparticles for the Treatment of Colorectal Cancer
Ying, K., Bai, B., Gao, X., Xu, Y., Wang, H., & Xie, B. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.670124 · Cited by 50
Targeting the devil: Strategies against cancer-associated fibroblasts in colorectal cancer
Chen, Y., Liang, Z., & Lai, M. (2024) · Translational research · doi:10.1016/j.trsl.2024.04.003 · Cited by 48
Giustarini, G., Pavesi, A., & Adriani, G. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.689245 · Cited by 48
Li, Z., Ning, F., Wang, C., Yu, H., Ma, Q., & Sun, Y. (2021) · Nanoscale · doi:10.1039/d1nr03387e · Cited by 46
Abedi, M., Abolmaali, S. S., Abedanzadeh, M., Farjadian, F., Mohammadi‐Samani, S., & Tamaddon, A. M. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s245135 · Cited by 40
Recent Advances in Nanoplatform Construction Strategy for Alleviating Tumor Hypoxia
Shen, J., Chen, G., Zhao, L., Huang, G., Liu, H., Liu, B., Miao, Y., & Li, Y. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300089 · Cited by 35
Pornpitchanarong, C., Rojanarata, T., Opanasopit, P., Ngawhirunpat, T., & Patrojanasophon, P. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110566 · Cited by 36
Emerging trends in the application of gold nanoformulations in colon cancer diagnosis and treatment
Aldahhan, R., Almohazey, D., & Khan, F. A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.11.008 · Cited by 39
Nanovectors Design for Theranostic Applications in Colorectal Cancer
Rampado, R., Crotti, S., Caliceti, P., Pucciarelli, S., & Agostini, M. (2019) · Journal of Oncology · doi:10.1155/2019/2740923 · Cited by 32
Application of different nanoparticles in the diagnosis of colorectal cancer
Ghorbani, F., Kokhaei, P., Ghorbani, M., & Eslami, M. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100896 · Cited by 29
Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders
Sofias, A. M., Lorenzi, F. D., Peña, Q., Shalmani, A. A., Vucur, M., Wang, J., Kiessling, F. M., Shi, Y., Consolino, L., Storm, G., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113831 · Cited by 28
Abedi, M., Abolmaali, S. S., Heidari, R., Mohammadi‐Samani, S., & Tamaddon, A. M. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120685 · Cited by 27
Sayed, Z. S., Hieba, E. M., Batakoushy, H. A., Rashdan, H. R. M., Ismail, E., Elkatlawy, S. M., & Elzwawy, A. (2024) · RSC Advances · doi:10.1039/d4ra06992g · Cited by 26
Ferreira, B. J. M. L., Martel, F., Silva, C., Santos, T. M., & Daniel‐da‐Silva, A. L. (2020) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2020.111258 · Cited by 24
Fakhri, S., Moradi, S. Z., Faraji, F., Farhadi, T., Hesami, O., Iranpanah, A., Webber, K. J., & Bishayee, A. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10119-w · Cited by 25
Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments
Avgoustakis, K., & Angelopoulou, A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020179 · Cited by 26
Cruz-Nova, P., Ancira-Cortez, A., Ferro‐Flores, G., Ocampo‐García, B., & Gibbens-Bandala, B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051095 · Cited by 22
Gold nanoparticles and obese adipose tissue microenvironment in cancer treatment
Essa, N., O’Connell, F., Prina‐Mello, A., O'Sullivan, J. N., & Marcone, S. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.017 · Cited by 20
González-Ballesteros, N., Maietta, I., Rey-Méndez, R., Rodríguez-Argüelles, M. C., Lastra, M., Cavazza, A., Grimaldi, M., Bigi, F., & Simón‐Vázquez, R. (2022) · Marine Drugs · doi:10.3390/md21010020 · Cited by 20
Meng, X., Ma, F., & Yu, D. (2023) · Environmental Research · doi:10.1016/j.envres.2023.117362 · Cited by 19
Xia, C., Pan, J., Wang, J., Pu, Y., Zhang, Q., Hu, S., Hu, Q., & Wang, Y. (2020) · Nanoscale · doi:10.1039/d0nr04682e · Cited by 18
Self-citationGold Nanopeanuts as Prospective Support for Cisplatin in Glioblastoma Nano-Chemo-Radiotherapy
Depciuch, J., Miszczyk, J. U., Maximenko, A., Zieliński, P. M., Rawojć, K., Panek, A., Olko, P., & Parlińska‐Wojtan, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239082 · Cited by 18
Recent advances in the nanoparticle-based targeted cancer treatment: A review
Uddin, H. M. W., Progoti, Q. R. M., Rahman, A. F. M. M., Osman, A. I., & Salem, K. S. (2025) · Next Bioengineering · doi:10.1016/j.nxbio.2025.100011 · Cited by 24
Smart delivery vehicles for cancer: categories, unique roles and therapeutic strategies
Zeng, Y., Gao, Y., He, L., Ge, W., Wang, X., Ma, T., & Xie, X.-Y. (2024) · Nanoscale Advances · doi:10.1039/d4na00285g · Cited by 16
Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy
Zhang, Z., Wang, R., & Chen, L. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s500591 · Cited by 17
Nanotechnology in Cancer Therapy: How Nanoparticles Are Shaping the Future of Personalized Treatment
Lionadi, I., & Payam, A. F. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00117 · Cited by 16
Yunna, C., Hu, M., Fengling, W., Wang, L., & Weidong, C. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.05.007 · Cited by 15
Recent Advances on Pt-Based Compounds for Theranostic Applications
Ferrari, G., Lopez-Martinez, I., Wanek, T., Kuntner, C., & Montagner, D. (2024) · Molecules · doi:10.3390/molecules29153453 · Cited by 14
Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
Zhang, Z., & Chen, L. (2025) · Cancer Nanotechnology · doi:10.1186/s12645-024-00302-1 · Cited by 15
Sharma, S., Bhattacharya, S., Joshi, K., & Singh, S. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05331-8 · Cited by 13
Application of Nanoparticles in the Diagnosis and Treatment of Colorectal Cancer
Song, Q., Zheng, Y., Zhong, G., Wang, S., He, C., & Li, M. (2024) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206323900240807110122 · Cited by 11
Chu, X., Lin, Z.-B., Huang, T., Ding, H., Zhang, Y., Zhao, Z., Huangfu, S., Qiu, S., Guo, Y., Chu, X.-L., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-09201-3 · Cited by 11
Self-citationUggioni, M. L. R., Feuser, P. E., Possato, J. C., de Melo, M. E., Pieri, E. D., Cercená, R., Dal‐Bó, A. G., da Rosa, M. I., & Machado‐de‐Ávila, R. A. (2022) · Gold bulletin · doi:10.1007/s13404-021-00305-5 · Cited by 11
Pectinas modificadas con actividad contra el cáncer de colon: Una revisión sistemática de 2010-2021
Pérez-Loyola, M., Valdés, M., & Garrido, G. (2022) · Journal of Pharmacy & Pharmacognosy Research · doi:10.56499/jppres22.1387.10.4.616 · Cited by 10
Ibrahim, B., Akere, T. H., Chakraborty, S., Valsami‐Jones, E., & Ali‐Boucetta, H. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030380 · Cited by 10
Tian, S. I. P., & Chen, M. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1460201 · Cited by 8
Mukherjee, K., Dutta, P., Dey, S., & Giri, T. K. (2024) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2024.100137 · Cited by 11
Hybrid AuNPs-3MPS-MTX nanosystem and its evaluation for treating cervical cancer and melanoma
Hernández-Esparza, M. J., Fratoddi, I., Cerra, S., Juárez‐Moreno, K., & Huirache-Acuña, R. (2023) · Nanoscale Advances · doi:10.1039/d3na00605k · Cited by 7
Saadh, M. J., Mustafa, M. A., Malathi, H., Ahluwalia, G., Kaur, S., Faisal, A. N., Alubiady, M. H. S., Al‐Abdeen, S. H. Z., Shakier, H. G., Ali, Z. H., et al. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105938 · Cited by 8
Targeted Nanoparticles: the Smart Way for the Treatment of Colorectal Cancer
Abdellatif, A. A. H., Alshubrumi, A. S., & Younis, M. A. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02734-9 · Cited by 8
Włodarczyk, J., Krajewska, J. B., Talar, M., Szeleszczuk, Ł., Gurba, A., Lipiec, S., Taciak, P., Szczepaniak, R., Młynarczuk-Biały, I., & Fichna, J. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00558-1 · Cited by 6
Desai, M. K., Parmar, N. B., Shah, I. T., Parekh, P. S., Patel, R., & Chorawala, M. R. (2025) · Developmental Dynamics · doi:10.1002/dvdy.70042 · Cited by 5
Diagnostic innovations and therapeutic potential of nanoparticulate delivery for colon cancer
Roy, A., Adnan, M., Ghosh, V., & Ajazuddin, M. (2024) · Nano-Structures & Nano-Objects · doi:10.1016/j.nanoso.2024.101426 · Cited by 4
Kumar, L., Verma, S., Joshi, K., & Sharma, S. (2022) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2022039548 · Cited by 4
Nanotechnology a Boon for Colorectal Cancer Treatment
Kriplani, P., & Guarve, K. (2022) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892817666221011094619 · Cited by 4
Nanoparticulate drug delivery systems for colonic disorders
Kumar, G., Virmani, T., Sharma, A., Virmani, R., & Pathak, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14044-0.00009-0 · Cited by 5
Recent Developments and Challenges in Nanoformulations Targeting Various Ailments of the Colon
Mishra, N., Singh, S., Maurya, P., Nisha, R., & Saraf, S. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-41858-8_7 · Cited by 2
The comparison of gold nanoparticles effectiveness in 2D and 3D cell culture.
Musielak, M., Szymkowiak, B., & Boś, A. (2023) · Letters in Oncology Science · doi:10.21641/los.2023.20.1.239 · Cited by 1
Applications of nanocarriers in colon targeting
DCruz, C. E. M., Kumar, L., & Shirodkar, R. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24806-1.00004-2 · Cited by 1
Emerging agents that target signaling pathways in cancer fibroblast cells (Review)
Wan, Y., Liu, X.-Q., Liu, D., Li, K.-D., & Zhang, D. (2026) · International Journal of Oncology · doi:10.3892/ijo.2026.5900 · Cited by 1
Jiang, Y., Ding, B., Yin, H., Hua, Y., Ma, N., Hu, P., Deng, J., Wu, F.-G., & Shen, Y. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01845-z · Cited by 1
NANOCZĄSTKI ZŁOTA W DIAGNOSTYCE I TERAPII NOWOTWORÓW – WYBRANE ZASTOSOWANIA
Balcer, E., & Mazur, M. (2020) · Prospects in Pharmaceutical Sciences · doi:10.56782/pps.18 · Cited by 1
Synthesis and Biological Use of Nanomaterials
Hatipoglu, M. K., & Süt, P. A. (2022) · Topics in applied physics · doi:10.1007/978-3-030-93460-6_29
Archana, & Deshmukh, R. (2024) · Current Cancer Therapy Reviews · doi:10.2174/0115733947279599231208095726
Gold nanoparticles in colon targeting
Ranch, K. M., Jani, H., Patel, Y. H., Patel, C. A., Babu, R. J., Tiwari, A. K., Bhandare, R. R., & Boddu, S. H. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24806-1.00012-1
Rao, S. A., Varenya, V., Samanvitha, H. S., Prasad, S. N., Paari, K. A., & George, J. A. (2025) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2025-35-3-7-20
Application of gold nanoparticles in dentistry
Cherian, T., Varghese, N., Jacob, J., & Sadaka, M. C. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-31392-9.00013-3
Current Insights into Interaction of Metallic Nanoparticles with the Tumor MicroenvironmentPreprint
Caro, C., Hellevik, T., & Martínez-Zubiaurre, I. (2026) · Preprints.org · doi:10.20944/preprints202601.1013.v1 · Cited by 1
Yang, Z.-H., Huang, Q.-L., Luo, L., Wu, X.-X., Nie, S.-W., & Xu, M. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.121133
Oladunjoye, B. B., Sibuyi, N. R. S., Meyer, M. D., Meyer, M., & Madiehe, A. M. (2026) · Molecules · doi:10.3390/molecules31183150
Abuhassan, Q., Sayed, U., Patel, P. N., Jyothi, S. R., Singh, G., Nayak, P. P., Arora, V., & Shakhmurova, G. (2026) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.47456
Metadata
- Authors
- Zhao, X., Pan, J., Li, W., Yang, W., Qin, L., & Pan, Y.
- Affiliations
- First Affiliated Hospital of Jinan University (CN)
- Corresponding author
- Pan, Yunlong
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2018-10
- Volume
- Volume 13
- Pages
- 6207-6221
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- PMC
- PMC6188185
- OpenAlex
- W2895615845
- Cited by
- 75
- References
- 52
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 14 · 2023: 9 · 2022: 13 · 2021: 12 · 2020: 10 · 2019: 4
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Nanomedicine (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- National Natural Science Foundation of China (81472849)
- Jinan University
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- gold nanoparticles, cisplatin, colorectal cancer, solid stress, tumor hypoxia, tumor stroma, type I collagen, cancer-associated fibroblasts, connective tissue growth factor, TGF-β1, vascular endothelial growth factor, Akt signaling, chemosensitization, drug delivery
- MeSH terms
- Cancer-Associated Fibroblasts, Animals, Cell Count, Cisplatin, Colonic Neoplasms, Endocytosis, Female, Fibrosis, Gold, Humans, Mice, Inbred BALB C, Mice, Nude, Oxygen, Perfusion, Colorectal Neoplasms, Signal Transduction, Cell Hypoxia, Cytokines, Drug Delivery Systems, Treatment Outcome, Stromal Cells, Collagen Type I, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Proto-Oncogene Proteins c-akt, Metal Nanoparticles, Transforming Growth Factor beta1, Connective Tissue Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.